Wuxi Zhongkun biochemical technology Co., Ltd. - China

Welcome to

Wuxi Zhongkun biochemical technology Co., Ltd.

Free Member

Wuxi Zhongkun biochemical technology Co., Ltd.
China

Home
Company Info
Contact Us
Share your thoughts
Language
- English

Company Profile

Company Contact

Name:

Mr. Zhang Yf

E-mail:

Send Message

Instant Messaging:

Mobile Number:

Phone Number:

Address:

Wuxi, Jiangsu
China

Average User Review

There is no review for this company - Write a review

Registration Date:

Jun. 25, 2024

Last Updated:

Mar. 2, 2013

Business Nature:

Manufacturing, Trade of Chemicals category

Want to contact this company?

Send Message

Your inquiry will be recorded in "Member Trade Mail".

Put on Company Partner

Recommend to your friends

Company Brief

Wuxi Zhongkun Biochemical Technology Co., Ltd. is a joint investment of two shareholders of the listed company in Xiamen and Wuxi Fine Chemicals R & D, production, sales and integration of high-tech enterprises, the Wuxi factory and R & D center in Shanghai, Shijiazhuang R & D Center, Nanjing R & Dmarketing headquarters in the center of Yangzhou in the pilot plant.
The company is located in the beautiful Taihu Lake - Wuxi, China Lakeside Taihu Lake Technology Park near the Wuxi Airport as well as the Beijing-Shanghai Expressway, from a half hour drive, surrounded Jiangnan University and Southeast University Campus, superior geographical location, unique ecological environment and stable human resources for the company' s long-term development has laid a good foundation.
The company was founded in 2006, has four R & D center and production base in Shanghai, Shijiazhuang, Nanjing, Wuxi. Shanghai R & D center in pharmaceutical intermediates series-based small molecule heterocyclic, flavors, spices and food additives, the R & D Center of Shijiazhuang, Nanjing R & D center in the heterocyclic series, Wuxi plant to produce OLED intermediates and electronic materials Lord. In addition, Yangzhou and a pilot plant room.

I am familiar with this company and want to review it.

You have [3] new inquiries.